Christine M Bestvina

7PUBLICATIONS
85CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 23, 2025
Bridging EGFR/TGF-β Signaling to Bypass Resistance to Immune Checkpoint Blockade.

Noura J Choudhury, Aditi Kothari, Christine M Bestvina

|Sep 15, 2025
Positioning amivantamab and lazertinib in the therapeutic sequence for EGFR-mutant NSCLC: insights from CHRYSALIS-2 cohort A.

Faith Abodunrin, Dillon E Berlin, Christine M Bestvina

|Jun 23, 2023
Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal.

Christine M Bestvina, Marina C Garassino, Joel W Neal

|Apr 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.

Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti

|Jan 05, 2023
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.

Rohan R Katipally, Liam F Spurr, Stanley I Gutiontov

|Nov 24, 2022
Immunotherapy partners after progression: Right place, right time?

Sherin J Rouhani, Christine M Bestvina

Pageof 2